PNPaul Ndebele

Paul Ndebele

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Paul Ndebele has a total of 212 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Strengthening Research Ethics Capacity in West Africa, 2015–2024

    by Kyle Ferguson, Clement Adebamowo, Adebayo O. Adejumo, Temidayo Ogundiran, Muktar H. Aliyu, Elisa J. Gordon, Zubairu Iliyasu, Christopher Agulanna, Shehu U. Adamu, Olusegun Adeyemo, et al.

    This article reviews the development and evolution of Fogarty International Center–funded research ethics training programs in West Africa over the past decade. In response to local and global challenges in bioethics and biomedical research, these programs are fostering ethical awareness, shaping local and national ethics review systems, and enhancing bioethics capacity in the region. These efforts have expanded alongside increased democratic governance, technological advances, and significant increases in global research funding and international research collaborations, particularly related to HIV/AIDS and malaria. We believe that the West Africa Bioethics (WAB) Training Program in Nigeria played a central role in this growth, serving as a model for subsequent programs in Ghana, Mali, and The Gambia. This paper describes the nature, successes, and challenges of these programs. It also outlines an agenda and strategies for future work to enhance research ethics and bioethics capacities in the region, both in terms of education and governance.


  • Open Access

    Health Research Ethics in Southern Africa: Building Capacity and Cultivating Excellence

    by Zaynab Essack, Paul Ndebele, Heidi Matisonn, Jantina de Vries, Keymanthri Moodley, Stuart Rennie, Joseph Ali, Nancy Kass, Carel Ijsselmuiden, Nhlanhla Mkhize, et al.

    The health research landscape in southern Africa is becoming increasingly complex as research efforts intensify to address the region's significant disease burden. The increasing volume and complexity of health research in low- and middle-income countries (LMICs) highlights the ongoing need for enhanced research ethics capacity. To supplement a review published in 2014, this paper provides an overview of research ethics capacity-building initiatives supported through substantive long-term competitive awards from the Fogarty International Center of the US National Institutes of Health between 2014 and 2024. These programs aimed to enhance the capabilities of research ethics committees (RECs) and strengthen research ethics capacity throughout Southern Africa, with broader benefits to the African continent and globally as collaborative health research increases. The programs have successfully developed and delivered comprehensive research ethics curricula tailored to research ethics concerns in the region. Trainees and graduates include clinicians, researchers, REC members, REC administrators, lawyers, and ethicists, with focused efforts to ensure gender parity. This increased representivity of scholars has improved the membership on RECs and in skilled research ethics leadership in the region. For the benefit of future planning, this paper also describes some of the many challenges faced in delivering on program goals – including COVID-19. We also describe innovative solutions developed to address these challenges and meet the needs of students, faculty and institutions, while cultivating excellence in health research ethics. The paper concludes by highlighting areas for future research, underscoring the importance of continued diverse global investment in research ethics capacity to protect research participants and maintain and improve ethical standards and practice in health research within the region and globally. This will enable the development of innovative evidence-based global health solutions based on ethical research.


  • Open Access

    PA-16 Strengthening research ethics oversight in Botswana – The case of University of Botswana

    by Paul Ndebele, Dimpho Ralefala, Joseph Br Gaie

    Background The University of Botswana (UB) received a grant from the European and Developing Countries Clinical Trials Partnership (EDCTP) from 2011 to 2013. The overall aim of the grant was to strengthen capacity for ethical review and promote ethical conduct of research at UB. This paper presents findings from a study that evaluated the impact associated with the implementation of the grant on the research ethics processes at UB. Methods Through a document review, the funded project plan, including targets, tasks and milestones, were assessed against the met deliverables, achievements and impact associated with the project. Results The grant enabled the establishment of a Research Ethics Office, which is now a permanent structure, providing ethics oversight to all research conducted by the University research community. In addition, an IRB Administrative Officer was hired to coordinate the activities of the IRB and now heads the Research Ethics Unit. The grant also facilitated the acquisition of office equipment that contributed to improving the operations of the committee, including speeding up the ethics review process and communication with stakeholders. Standard Operating Procedures and guidelines on human research were developed, and several workshops held for graduate students and university staff. Furthermore, the grant facilitated IRB staff and some committee members to attend short courses on research ethics in South Africa, hence enhanced their skills and knowledge. Finally, key government stakeholders responsible for the issuance of research permits were involved in a workshop that reviewed and streamlined the review process and reduced the turnaround time for issuance of research permits. Conclusion The EDCTP grant was critical in strengthening the research ethics oversight structures at the University of Botswana. These structures and processes have the potential to serve as a best practice model for other Universities intending to establish Research Ethics units in Botswana and beyond.

  • The role of science granting councils in promoting ethics in research and innovation: strategies used by selected African SGCs in promoting ethics in research and innovation

    by Paul Ndebele, Zivai Nenguke, Tiwonge Mtande, Kachedwa Mike, Samba Corr, Matandika Limbanazo, Lillian Naigaga Mutengu, Jonathan Mba, Maurice Bolo

    The Science Granting Councils Initiative (SGCI) in Africa aims to strengthen the capacities of selected science granting councils (SGCs) in sub-Saharan Africa in order to support research and evidence-based policies that will contribute to Africa’s economic and social development. As part of SGCI, a study was conducted in 2021 to investigate strategies that have been adopted by fifteen SGCs participating in SGCI in promoting ethical practice in research and innovation. Data collection for the study was mainly based on a data abstraction form that was completed for each country by an assigned focal person with a background in research ethics. The focal persons relied on various methods including document and website review and interviews with senior officers at the SGCs. The study specifically sought to describe the strategies and activities being implemented by the 15 SGCs in promoting ethics and integrity in research and innovation. The study revealed various strategies that were being implemented by the 15 SGCs aimed at promoting ethics in research and innovation including requiring proof of research ethics committee approval before releasing research funds and the inclusion of ethics questions in the application form for funding. It was observed that some activities and strategies were generic to most SGCs for example the development of general/standard guidelines for the conduct of research in each respective country. Overall, the different SGCs were involved in a broad spectrum of activities aimed at promoting research ethics and this paper presents an opportunity for cross fertilization of ideas. By providing a summary of the various strategies that SGCs are using in promoting ethical conduct of research, it is hoped that this paper will lead to improvements in the ways SGCs provide support and oversight over the research that they fund.


  • Open Access

    Evaluating industry attempts to influence public health: Applying an ethical framework in understanding commercial determinants of health

    by Paul Ndebele, Perrin Krisko, Imran Bari, Nino Paichadze, Adnan A. Hyder

    Objectives: This paper explores industry influence on public health using a specific case study and applies an established ethical framework based on eleven principles to explore Commercial Determinants of Health (CDoH). It demonstrates an application of these principles to evaluate the ethical integrity of industry strategies and practices and their impacts on public health.Methods: Using eleven a priori, deductive, ethical principles as codes, this paper conducted an in-depth analysis of 19 e-mail chains and accompanying documents made publicly available through the Freedom of Information Act (FOIA) from U.S. Right to Know (USRTK) sent between Coca-Cola representatives, lobbyists, academics, and the International Life Sciences Institute (ILSI), founded by former Coca-Cola executives.Results: The three principles violated most frequently amongst the documents were consumer sovereignty (n = 22), evidence-informed actions (n = 21), and transparency (n = 20). Similarly, codes that featured most regularly across documents were transparency (13 out of 19 documents), consumer sovereignty (13 out of 19 documents), evidence-informed actions (9 out of 19 documents), and social justice and equity (9 out of 19 documents). All eleven principles were applied at least four times throughout the documents; however, responsiveness (z = 12), moral responsibility (z = 16), and holism (z = 30) were the least relevant to the data set.Conclusions: This case study of Coca-Cola demonstrates the usefulness of this ethics framework in reviewing actions of corporate actors in the promotion of products that are harmful to human health. It shows that the industry at times has low ethical integrity in their various strategies and practices to promote their products despite the negative impacts of these products on public health.


  • COVID-19 vaccine mandate for healthcare workers in the United States: a social justice policy

    by Kobina Hagan, Rebecca Forman, Elias Mossialos, Paul Ndebele, Adnan A. Hyder, Khurram Nasir

    Vaccination is the most effective strategy to mitigating the COVID-19 pandemic and restoring societal function. As the pandemic evolves with no certainty of a herd immunity threshold, universal vac...


  • Open Access

    Proceedings of an expert workshop on community agreement for gene drive research in Africa - Co-organised by KEMRI, PAMCA and Target Malaria

    by Delphine Thizy, Lea Pare Toe, Charles Mbogo, Damaris Matoke-Muhia, Vincent Pius Alibu, S. Kathleen Barnhill-Dilling, Tracey Chantler, Gershom Chongwe, Jason Delborne, Lydia Kapiriri, et al.

    Gene drive research is progressing towards future field evaluation of modified mosquitoes for malaria control in sub-Saharan Africa. While many literature sources and guidance point to the inadequacy of individual informed consent for any genetically modified mosquito release, including gene drive ones, (outside of epidemiological studies that might require blood samples) and at the need for a community-level decision, researchers often find themselves with no specific guidance on how that decision should be made, expressed and by whom. Target Malaria, the Kenya Medical Research Institute and the Pan African Mosquito Control Association co-organised a workshop with researchers and practitioners on this topic to question the model proposed by Target Malaria in its research so far that involved the release of genetically modified sterile male mosquitoes and how this could be adapted to future studies involving gene drive mosquito releases for them to offer reflections about potential best practices. This paper shares the outcomes of that workshop and highlights the remaining topics for discussion before a comprehensive model can be designed.


  • Promoting Ethical Payments in Human Challenge Studies Conducted in LMICs: Are We Asking the Right Questions?

    by Paul Ndebele, Adnan A. Hyder

    The paper by Lynch et al. (2021) raises interesting ethical questions regarding whether and how much SARS-CoV-2 Human Challenge Studies (HCS) participants should be paid. We appreciate the timely e...


  • Open Access

    Proceedings of an expert workshop on community agreement for gene drive research in Africa - Co-organised by KEMRI, PAMCA and Target Malaria

    by Delphine Thizy, Lea Pare Toe, Charles Mbogo, Damaris Matoke-Muhia, Vincent Pius Alibu, S. Kathleen Barnhill-Dilling, Tracey Chantler, Gershom Chongwe, Jason Delborne, Lydia Kapiriri, et al.

    Gene drive research is progressing towards future field evaluation of modified mosquitoes for malaria control in sub-Saharan Africa. While many literature sources and guidance point to the inadequacy of individual informed consent for any genetically modified mosquito release, including gene drive ones, (outside of epidemiological studies that might require blood samples) and at the need for a community-level decision, researchers often find themselves with no specific guidance on how that decision should be made, expressed and by whom. Target Malaria, the Kenya Medical Research Institute and the Pan African Mosquito Control Association co-organised a workshop with researchers and practitioners on this topic to question the model proposed by Target Malaria in its research so far that involved the release of genetically modified sterile male mosquitoes and how this could be adapted to future studies involving gene drive mosquito releases for them to offer reflections about potential best practices. This paper shares the outcomes of that workshop and highlights the remaining topics for discussion before a comprehensive model can be designed.


  • Commercial determinants of health: an ethical exploration

    by Paul Ndebele, Hina Shaikh, Nino Paichadze, Imran Bari, David Michaels, Carlos Santos Burgoa, Adnan A. Hyder

    Objectives This paper seeks to contribute toward a better understanding of commercial determinants of health by proposing a set of ethical principles that can be used by researchers and other health actors in understanding and addressing Commercial Determinants of Health (CDoH). Methods The paper is mainly based on a systematic review and qualitative analysis of the existing literature on CDoH and public health ethics frameworks. We conducted searches using selected search engines (Google Scholar and Pubmed). For ethical challenges relating to CDOH, our searches in Google Scholar yielded 17 papers that discussed ethical challenges that affect CDoH. For ethical frameworks relevant for CDOH, our searches in Google Scholar and Pubmed yielded 15 papers that clearly described bioethical models including relevant ethical principles. Additionally, we consulted eight experts working on CDoH. Through these two methods, we were able to identify ethical challenges as well as norms and values related to CDoH that we offer as candidates to comprise a foundational ethics framework for CDoH. Results Discussing risk factors associated with CDH frequently brings public health into conflict with the interests of industry actors in the food, automobile, beverage, alcohol, ammunition, gaming and tobacco industries including conflict between profit-making and public health. We propose the following candidate ethical principles that can be used in addressing CDoH: moral responsibility, nonmaleficence, social justice and equity, consumer sovereignty, evidence-informed actions, responsiveness, accountability, appropriateness, transparency, beneficence and holism. Conclusions We hope that this set of guiding principles will generate wider global debate on CDoH and help inform ethical analyses of corporate actions that contribute to ill health and policies aimed at addressing CDoH. These candidate principles can guide researchers and health actors including corporations in addressing CDoH.